C

Centro Regional Integrado de Oncologia | Fortaleza, Brazil

Research site
(Unclaimed)
Location
Rua Francisco Calaca, 1300, Álvaro Weyne, Fortaleza, Ceara, Brazil

Site insights

Top conditions

Top treatments

Capecitabine
Ipilimumab
Pembrolizumab
INCMGA00012
Pertuzumab
Platinum
Paclitaxel
Carboplatin
Lapatinib
Leuprolide Acetate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 9 total trials

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

The goal of this study is to evaluate the efficacy and safety of pembrolizumab combined with carboplatin and paclitaxel as first-line treatment in pa...

Active, not recruiting
Squamous Cell Carcinoma of Head and Neck
Drug: Pembrolizumab
Drug: Paclitaxel

This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast ca...

Enrolling
HER2 Positive Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants...

Enrolling
Melanoma
Renal Cell Carcinoma (RCC)
Drug: INCB 99280 with Ipilimumab

A Phase III, randomised, double-blind, placebo-controlled, multi-centre study to assess the efficacy of olaparib maintenance monotherapy in relapsed...

Active, not recruiting
Relapsed Ovarian Cancer
Following Complete or Partial Response to Platinum Based Chemotherapy
Drug: Olaparib 300mg tablets
Drug: Placebo to match olaparib 300mg

This is a phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 to suppress ovarian function in premenopausal women with HR+,...

Enrolling
Breast Cancer
Drug: Anastrozole Tablets
Drug: Tamoxifen

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metast...

Active, not recruiting
Metastatic Nonsquamous Non-Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Cancer
Drug: nab-Paclitaxel
Drug: Paclitaxel

Trial sponsors

Incyte logo
AstraZeneca logo
E
Merck Sharp & Dohme (MSD) logo
Pfizer logo
Puma Biotechnology logo
Seagen logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems